This study investigates the use of an investigational medication for advanced solid tumors. The purpose of this study is to evaluate the effects of the investigational medication alone and in combination with another treatment.
The study focuses on understanding the safety and potential effects of the investigational medication. Researchers will evaluate how well the investigational medication is tolerated by participants.
- Who can participate: Adults aged 18 and older with advanced solid tumors that have no standard treatment options or who are intolerant to these treatments can participate. Adequate organ function and other health criteria are required.
- Study details: Participants will receive the investigational medication and may also receive a combination treatment. In some cases, a placebo may be used, which is an inactive substance that looks like the investigational medication but does not contain any medicine.